FDA Warns Public About Unapproved Diabetes Management Devices

Devices for diabetes management. MCR/Kate/File Photo WASHINGTON D.C. — The U.S. Food and Drug Administration is warning patients and health care professionals of risks associated with the use of unapproved or unauthorized devices for diabetes management, including continuous glucose monitoring systems, insulin pumps and automated insulin dosing systems. In the safety communication issued May 17, Read more